Favourable long-term outcome after matched sibling transplantation for fanconi-anemia (FA) and in vivo T-cell depletion

K. Huck, H. Hanenberg, W. Nürnberger, D. Dilloo, S. Burdach, U. Göbel, H. J. Laws

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Hematopoietic stem cell transplantation is the only permanent treatment for the hematological manifestations in Fanconi anemia (FA). As FA patients have a dramatically increased intrinsic propensity to develop malignancies later in life and the genotoxic stress afflicted during conditioning advances the manifestation age especially of squamous cell carcinomas, choosing an optimally suited treatment regimen appears critical for long-term, tumor-free survival after stem cell transplantation. Here, we report our experiences in 6 consecutive FA patients transplanted with HLA-matched sibling donors where we combined an established pre-transplantation treatment consisting of thoraco-abdominal irradiation (TAI), cyclophosphamide (CYC) and cyclosporine A graft-versus-host prophylaxis with antibody-mediated in vivo T-cell depletion strategies after infusion of the graft. This approach has ensured sustained engraftment with long-term survival and an excellent post transplant performance status without any evidence of secondary malignancies in all six patients after a median follow-up of more than 10 years.

Original languageEnglish
Pages (from-to)147-152
Number of pages6
JournalKlinische Padiatrie
Volume220
Issue number3
DOIs
StatePublished - May 2008

Fingerprint

Fanconi Anemia
Siblings
Transplantation
T-Lymphocytes
Transplants
Neoplasms
Survival
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
Psychological Stress
Cyclophosphamide
Cyclosporine
DNA Damage
Squamous Cell Carcinoma
Therapeutics
Tissue Donors
Antibodies

Keywords

  • CD25 monoclonal antibody
  • Fanconi anemia
  • GvHD
  • Secondary malignancies
  • Stem cell transplantation

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Huck, K., Hanenberg, H., Nürnberger, W., Dilloo, D., Burdach, S., Göbel, U., & Laws, H. J. (2008). Favourable long-term outcome after matched sibling transplantation for fanconi-anemia (FA) and in vivo T-cell depletion. Klinische Padiatrie, 220(3), 147-152. https://doi.org/10.1055/s-2008-1065326

Favourable long-term outcome after matched sibling transplantation for fanconi-anemia (FA) and in vivo T-cell depletion. / Huck, K.; Hanenberg, H.; Nürnberger, W.; Dilloo, D.; Burdach, S.; Göbel, U.; Laws, H. J.

In: Klinische Padiatrie, Vol. 220, No. 3, 05.2008, p. 147-152.

Research output: Contribution to journalArticle

Huck, K, Hanenberg, H, Nürnberger, W, Dilloo, D, Burdach, S, Göbel, U & Laws, HJ 2008, 'Favourable long-term outcome after matched sibling transplantation for fanconi-anemia (FA) and in vivo T-cell depletion', Klinische Padiatrie, vol. 220, no. 3, pp. 147-152. https://doi.org/10.1055/s-2008-1065326
Huck, K. ; Hanenberg, H. ; Nürnberger, W. ; Dilloo, D. ; Burdach, S. ; Göbel, U. ; Laws, H. J. / Favourable long-term outcome after matched sibling transplantation for fanconi-anemia (FA) and in vivo T-cell depletion. In: Klinische Padiatrie. 2008 ; Vol. 220, No. 3. pp. 147-152.
@article{5ffc81b8c456482fa216361d581fae96,
title = "Favourable long-term outcome after matched sibling transplantation for fanconi-anemia (FA) and in vivo T-cell depletion",
abstract = "Hematopoietic stem cell transplantation is the only permanent treatment for the hematological manifestations in Fanconi anemia (FA). As FA patients have a dramatically increased intrinsic propensity to develop malignancies later in life and the genotoxic stress afflicted during conditioning advances the manifestation age especially of squamous cell carcinomas, choosing an optimally suited treatment regimen appears critical for long-term, tumor-free survival after stem cell transplantation. Here, we report our experiences in 6 consecutive FA patients transplanted with HLA-matched sibling donors where we combined an established pre-transplantation treatment consisting of thoraco-abdominal irradiation (TAI), cyclophosphamide (CYC) and cyclosporine A graft-versus-host prophylaxis with antibody-mediated in vivo T-cell depletion strategies after infusion of the graft. This approach has ensured sustained engraftment with long-term survival and an excellent post transplant performance status without any evidence of secondary malignancies in all six patients after a median follow-up of more than 10 years.",
keywords = "CD25 monoclonal antibody, Fanconi anemia, GvHD, Secondary malignancies, Stem cell transplantation",
author = "K. Huck and H. Hanenberg and W. N{\"u}rnberger and D. Dilloo and S. Burdach and U. G{\"o}bel and Laws, {H. J.}",
year = "2008",
month = "5",
doi = "10.1055/s-2008-1065326",
language = "English",
volume = "220",
pages = "147--152",
journal = "Klinische Padiatrie",
issn = "0300-8630",
publisher = "Georg Thieme Verlag",
number = "3",

}

TY - JOUR

T1 - Favourable long-term outcome after matched sibling transplantation for fanconi-anemia (FA) and in vivo T-cell depletion

AU - Huck, K.

AU - Hanenberg, H.

AU - Nürnberger, W.

AU - Dilloo, D.

AU - Burdach, S.

AU - Göbel, U.

AU - Laws, H. J.

PY - 2008/5

Y1 - 2008/5

N2 - Hematopoietic stem cell transplantation is the only permanent treatment for the hematological manifestations in Fanconi anemia (FA). As FA patients have a dramatically increased intrinsic propensity to develop malignancies later in life and the genotoxic stress afflicted during conditioning advances the manifestation age especially of squamous cell carcinomas, choosing an optimally suited treatment regimen appears critical for long-term, tumor-free survival after stem cell transplantation. Here, we report our experiences in 6 consecutive FA patients transplanted with HLA-matched sibling donors where we combined an established pre-transplantation treatment consisting of thoraco-abdominal irradiation (TAI), cyclophosphamide (CYC) and cyclosporine A graft-versus-host prophylaxis with antibody-mediated in vivo T-cell depletion strategies after infusion of the graft. This approach has ensured sustained engraftment with long-term survival and an excellent post transplant performance status without any evidence of secondary malignancies in all six patients after a median follow-up of more than 10 years.

AB - Hematopoietic stem cell transplantation is the only permanent treatment for the hematological manifestations in Fanconi anemia (FA). As FA patients have a dramatically increased intrinsic propensity to develop malignancies later in life and the genotoxic stress afflicted during conditioning advances the manifestation age especially of squamous cell carcinomas, choosing an optimally suited treatment regimen appears critical for long-term, tumor-free survival after stem cell transplantation. Here, we report our experiences in 6 consecutive FA patients transplanted with HLA-matched sibling donors where we combined an established pre-transplantation treatment consisting of thoraco-abdominal irradiation (TAI), cyclophosphamide (CYC) and cyclosporine A graft-versus-host prophylaxis with antibody-mediated in vivo T-cell depletion strategies after infusion of the graft. This approach has ensured sustained engraftment with long-term survival and an excellent post transplant performance status without any evidence of secondary malignancies in all six patients after a median follow-up of more than 10 years.

KW - CD25 monoclonal antibody

KW - Fanconi anemia

KW - GvHD

KW - Secondary malignancies

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=44449163396&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=44449163396&partnerID=8YFLogxK

U2 - 10.1055/s-2008-1065326

DO - 10.1055/s-2008-1065326

M3 - Article

VL - 220

SP - 147

EP - 152

JO - Klinische Padiatrie

JF - Klinische Padiatrie

SN - 0300-8630

IS - 3

ER -